Application of standardized mistletoe extracts augment immune response and down regulates metastatic organ colonization in murine models

被引:14
作者
Braun, JM
Ko, HL
Schierholz, JM
Weir, D
Blackwell, CC
Beuth, J
机构
[1] Univ Cologne, Inst Sci Evaluat Naturopathy, D-50931 Cologne, Germany
[2] Univ Edinburgh, Dept Med Microbiol, Edinburgh, Midlothian, Scotland
[3] Ctr Adv European Studies & Res, D-53111 Bonn, Germany
关键词
standardized mistletoe extract; BALB/c-mice; immunomodulation; antimetastatic activity;
D O I
10.1016/S0304-3835(01)00517-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
The immunomodulatory and antimetastatic activity of standardized aqueous mistletoe extracts from plants grown on fir trees (ME-A) and pine trees (ME-P) were evaluated in BALB/c-mice. Regular subcutaneous (s.c.) and intraperitoneal (i.p.) applications (three times per week for 14 consecutive days; 5 and 50 mug per injection and mouse) upregulated thymus weight and peripheral blood leukocyte counts in tumor bearing mice. To check the influence of ME-A and ME-P treatment on growth of experimental metastases, RAW 117 H 10 lymphosarcoma cells and L-1 sarcoma cells were intravenously inoculated into BALB/c-mice to establish liver and lung colonization. ME-A and ME-P were regularly administered starting 24 h after tumor cell challenge. Organ colonization was investigated on day 14 after tumor cell inoculation and demonstrated statistically significant (P < 0.05) reductions of experimental liver and lung metastases for ME-A and ME-P treated mice. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:25 / 31
页数:7
相关论文
共 23 条
[1]
BEUTH J, 1991, In Vivo (Attiki), V5, P29
[2]
Modulating activity of mistletoe lectins 1 and 2 on the lymphatic system in BALB/c-mice [J].
Beuth, J ;
Stoffel, B ;
Samtleben, R ;
Staak, O ;
Ko, HL ;
Pulverer, G ;
Wagner, H .
PHYTOMEDICINE, 1996, 2 (03) :269-273
[3]
Thymosin α1 application augments immune response and down-regulates tumor weight and organ colonization in BALB/c-mice [J].
Beuth, J ;
Schierholz, JM ;
Mayer, G .
CANCER LETTERS, 2000, 159 (01) :9-13
[4]
Clinical relevance of immunoactive mistletoe lectin-I [J].
Beuth, J .
ANTI-CANCER DRUGS, 1997, 8 :S53-S55
[5]
BEUTH J, 2000, J ONCOL, V32, P45
[6]
BRAUN JM, 1995, ZBL BAKT-INT J MED M, V283, P90
[7]
BUESSING A, 1999, Z ONKOL, V31, P35
[8]
Buessing A., 1996, APOPTOSIS, V1, P25
[9]
BUESSING A, 2000, MISTLETOE GENUS VISC, P123
[10]
Büssing A, 1999, ANTICANCER RES, V19, P3953